BSECompany Update5 Aug 2026 · 5 Aug 2026, 06:38 pm
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Medplus Health Services Ltd · 543427
✦ AI Summary▼ NegativeRegulatory
Medplus Health Services Ltd's subsidiary Optival Health Solutions Private Limited has received a two-day suspension order for a drug license for a store in Karnataka, resulting in a potential revenue loss of Rs 0.71 lacs.
Analysis Scores
Earnings Impact2/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact1/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
006a6278-00ae-4412-a114-3de8b275f6d4.pdf
View document text
MedPlus Health Services Limited
August 05, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received one suspension order for a Drug License of a store situated in the state of Karnataka:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of Date of receipt of Details of the Impact on
Authority the action(s) taken, direction or order, violation(s)/ financial
initiated or order(s) including any contravention(s) operation or
passed interim or interim committed or other activities
orders, or any alleged to be of the listed
other committed entity,
communication quantifiable in
from the monetary terms
authority to the extent
possible
Assistant Director, Suspension of Drug Order received on Under Rule 65 of Potential
Drugs Control License for two days of 04.08.2026 Drugs and Revenue Loss of
Administration, store situated at Jain Cosmetics Act, Rs 0.71 lacs.
Raichur Circle, Mandir Raichur, 1940 and Drugs
Raichur, Karnataka. Karnataka. and Cosmetics
Rules, 1945
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Shrenik Soni
Company Secretary & Compliance Officer
(M. No. F12400)
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com